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Summary: Detection of the psychostimulants pemoline (Tradon®), fenozolone (Ordinator ) and thozalinone
(Stimsen®) in biological samples (urine) presents certain experimental difficulties.
These substances were therefore converted by acid hydrolysis to their common hydrolysis product 5-phenyl-2,4-
oxazolidinedione, which can be detected with high sensitivity and selectivity by thin layer chromatography.
After silylation with N-methyl-N-trimethylsilyltrifluoroacetamide/triinethylchlorosilane quantitative results can be
obtained from the same extract by the proposed GC/MS-method. After a single dose of 30 mg pemoline, levels
ranging from one to four mg/1 urine were observed.
Nachweis der Psychostimulantien Pemoline, Fenozolone und Thozalinone im menschlichen Harn mit Gaschromato-
graphie/Massenspektrometrie und Dünnschichtchromatographie
Zusammenfassung: Der Nachweis der Psychostimulantien Pemoline (Tradon®), Fenozolone (Ordinator®) und
Thozalinone (Stimsen®) im biologischen Material (Urin) bietet einige experimentelle Schwierigkeiten.
Daher wurden diese Verbindungen durch salzsaure Hydrolyse quantitativ in das 5-Phenyl-2,4-oxazolidindion
umgewandelt, welches sehr empfindlich und selektiv dünnschichtchromatographisch nachgewiesen werden kann.
Nach Silylierung mit N-Methyl-N-trimethylsilyltrifluoracetamid/Trimethylchlorsilan können quantitative Ergebnisse
mit Hilfe der hier vorgestellten GC/MS-Methode erzielt werden.
Nach einmaliger Einnahme von 30 mg Pemoline konnten so Werte zwischen ein und vier mg/1 im Harn gemessen
werden.
Introduction
For some years, the abuse of pemoline (I; Tradon®)1)
and its use äs a doping agent (1-6) have been a cause
for concern. Pemoline and its clpsely related derivatives,
fenozolone (II; Ordinator®)2) and thozalinone (III;
Stimsen®)3) are used medically äs psychostimulants
and antidepressants.
Chemically they are 5-phenyl-4-oxazolidinones:
I = 2-inüno-4-oxo-5-phenyloxazolidine,
II = 2-ethylamino-5-phenyl4-oxo-2-oxazoline and
III = 2-dimethylamino-5-phenyl4-oxo-2-oxazoline.
*) Beiersdorf, Hamburg
2) Lab. Dausse, Paris
3) Lederle, Pearl River, N. Y.
Pemoline was synthesized by Traube & A scher in 1913
(7); since then, many of its derivatives and analogs have
been synthesized and thoroughly tested for their
pharmacological activities (8,9). Their detection in
human urine is difficult because of their poor extraction
and (gas-) Chromatographie properties. GC-methods have
been published for I (10), but these include extensive,
time consuming preparations, e.g. special sample clean-
up, involving conversion to benzaldehyde by oxidative
degradation (l 1), or formation of derivatives (l, 2).
Other analytical approaches, e.g. paper-chromatography
(12), TLC (4,13), microsublimation (14), polarography
(15), UV-spectroscopy (4,11) and HPLC (16) are not
speciflc and sensitive enough for determinations in
biological fluids and/or not applicable for rapid
screening procedures.
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To overcome these obstacles, an efficient screening
procedure for the routine assay of pemoline misused in
Sports has been evaluated by quantitative estimation of
its metabolite mandelic acid (5) by mass fragmento-
graphy (6). The main drawback of this method is the
fact that a high mandelic acid level alone does not ful-
fill the requirements for a positive identification, since
mandelic acid is also a metabolite of other drugs and
some drug preparations contain mandelic acid esters
äs an active constituent.
The GC-methods of Venneulen, de Roode & Breimer
(1) and van Boven ScDaenens (2) seem to be more
practical but include the use of diazomethane, whose
dangerous chemical/biological properties prohibit its
wide application for routine ipurposes. In this paper a
similar method is presented which allows the simul-
taneous determination of these three drugs in urine via






Fig. 1. Structural formulae of the investigated drugs and their cpmmon hydrolysis product 5-phenyi-2,4-öxazolidinedione (IV).
For screening purposes a rapid and sensitive TLC-
method is recommended; quantitative results can be




All GC/MS-analyses4) were performed on a Finnigan 4023
according to I.e. (17); oven temperature was 180 °C iso-
thermically.
Mass spectra of II and III were obtained by solid probe inlet.
Thin layer chromatography
TLC-plates (
 254) were obtained from E. Merck, Darmstadt.
Solvent System: chloroform/acetone 80 ml + 20 ml.
For detection "Dresslers Reagent"5) (18) is most suitable,
giving bright red spots, changing to orange after 10 min. Less
than 0.5 Mg could easily be visualized. Rfvalues: I - 0.06,
II = 0.22, III = 0.37 and IV = 0.52. With Dragendorffs
reagent (and subsequently spraying a solution of 50 g/l
Fe(III)-chloride) only II and III were detectable.
) See "GC/MS Assays for Abused Drugs in Bpdy Fluids",
Chapter l + 2, by R. L. Foltz, A. F. Fentiman and R. B.
Foltz, NIDA Research Monograph 32, Aug. 1980.
5) Dressiert Reagent: Solution l = 200 g/l potassium hydroxide
in methanol;
Solution 2 = 10 g/l m-dinitrobenzene in
methanol.
Spray solution until plate is transparent, dry plate (hair-dryer)
then apply solution 2.
Extraction /hydrolysis
To 5 ml urine in a centrifuge tube l ml 6 mol/1 hydroehlorie
acid was added and heated for 15 min in an aluminium block .
at 80 °C. After adding 3 g of anhydrous sodiüm sulphate, the
cooled hydrolyzäte was extracted twice with 5 ml ether. After
centrifugation the organic phases were removed, cpllected and
evaporated to dryness in an N2 stream.
Derivatization
a) Silylation:
The extraction residue was dissolved in a mixture of 500
Nrmethy^N-trimethylsilyltri uoraceta nide and 20 trimethyl-
chlorosüane; the capped tube was left for half an hour at 60 °C.
Then 3 of the resulting solution were injected in the GC.
b) Alkylation:
Several alkylation procedures were tested to öbtain the desired
5-phenyl-2,4-oxazoiidmedione-N-alkyl derivative, mainly the
N^methyl derivative, according to the methöds described by
Kovat & Anderle (19) and Vycudilik (20), but no satisfactory
results were obtained.
Rena! excretion studies with pemoline
Three male, healthy human völunteers received one hour after
breakfast a single dose of 30 mg pemoline pfally. The urine
was collected during the following two days after administra-
tion; excretion was determined via the silylated 5-phenyl-2,4-
oxazolidinedipne. Quantification was achieved by spiking urine
sainples with authentic 5-phenyl-2,4^pxazolidinedione (concen-
tratiöns ranging frpm 0 to 20 mg/1) and direct comparisön of
the corresponding TLC-äreäs by pperating the GC/MS in the
chemical ipnisatipn (CI) mode (reagent gas: iso-^butane) and
recording the MH*-ion at m/z 250.
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Before starting these studics, a blank urine was collected and
treated in the same manner äs the drug-containing samples.
The coefficient of Variation (n = 5) was about 10%. Average
recovery based on thiee determinations was about 72%.
Reproducibiüty between duplicate injections was always
better than 8%.
Results and Discussion
On account of their polarity, pemoline, fenozolone and
thozalinone are difficult to extract from biological
fluids and to analyze; for instance none of them elutes
directly from the GC-column. Derivatization of the
compounds äs such leads to various products in
changing yields; a uniform product" was not attain-
able (1).
The cited experiments have shown that a method, based
on acidic hydrolysis to the 5-phenyl-2.4-oxazolidine-
dione meets the requirements for a rapid and sensitive
screening procedure in urine. Under the described condi-
tions this reaction is practically complete.
For screening purposes (or if a GC/MS is not available)
the presented TLC-method has its merits; this method
is very selective, for no other substance in human urine
reacts in the described characteristic manner with
Dressler?* reagent (4, 5): thus positive identifications
were achieved up to 24 hours after administration (of I).
\ quantitative results are needed, e.g. when pharmaco-
kinetie studies are on work, the proposed GC/MS method
should be employed: this includes silylation of IV with
N-methyl"N-trimethylsiIyltrifluoroacetamide, operäting
the GC/MS in the chemical ionisätion (CI-) mode and
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Fig. 2. Renal excretion of pemoline, determined by GC/MS via its
silylated degradation-product 5-phenyl-2,4-oxazolidine-
dione (IV) after Ingestion of 30 mg pemoline (i).
resulted in a better peak shape, lower detection limit
(approx. 15 ng absolutely) and - owing to the shorter
retention time — a more rapid analysis-time with respect
to the alkylation procedures cited.
To demonstrate the efficiency of the method, renal
studies were perforrned: after ingestion of 30 mg
pemoline, concentrations between l and 4 mg/1 were
observed (fig. 2).
For completeness, the mass spectra of fenozolone and
thozalinone are depicted in figures 3,4; the mass spectra
of compounds I and IV have been reported previously
0,2).
The preferred fragmentation pathway of them all is
cleavage of the bonds 1/2 and 4/5 with or without
hydrogen rearrangement (5). Which of the resulting
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Fig. 4. Electron impact (EI) mass spectrum of thozalinone (III)
by direct insertion.
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of the substituent at C-2 to stabilize a positive Charge:
in the case of substance IV this happens exclusively at
the fragments bearing the phenyl group (m/z 105-107,
89 and 90, 77-79). In contrast, in the case of substance
II, this occurs for the fragments bearing the amidine
group, äs shown by the intensities of the ions m/z 98
and 70. The mass spectrum of I is dominated by ions
containing the phenyl group, but m/z 70 is also clearly
visible with a relative intensity of 35%. A detailed dis-
cussion of the mass spectra of oxazolidinediones, e.g.
paramethadione, primidone and phenacemide, is pre-
sented by Locock & Coutts (21).
The electron impact (EI) mass spectrum of the N-tri-
methylsilyl derivative of 5-phenyl-2,4-oxazolidinedione
showed an intense M-l 5 peak (äs expected), but the
trimethylsilyl group did not influence the discussed
fragmentation pattern. Among fragments exceeding
m/z 200, this ion (= m/z 234) would be a good choice
for selected ion monitoring, but Optimum results were
obtained by operating the GS/MS in the chemical
ionisation (CI) mode and monitoring the quasi-
molecular ion (MH+) m/z 250, which contains over






Fig. 5. Chemical ionisation (CI) mass spectrum (with isp-
butane) of the 5-phenyl-2,4-oxazolidinedione-N!-trir
methylsilyl derivative.
Under these cönditions, up tp 10 sämples can be
analyzed within one hour.
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